Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

NCT07715929 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

710

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Obesity & Overweight
Catheter Ablation

Interventions

DRUG: Tirzepatide
BEHAVIORAL: Structured Lifestyle Intervention

Sponsor

Yunlong Wang